SEC Comment Letter 0000000000-23-011781 to Alvotech (ALVO)
Alvotech
Date: Oct. 26, 2023 · CIK: 0001898416 · Accession: 0000000000-23-011781
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275111
Letter
United States securities and exchange commission logo October 26, 2023 Tanya Zharov General Counsel Alvotech 1201 Wilson Blvd., Ste. 2130 Arlington, Virginia 22209 Re:Alvotech Registration Statement on Form F-3 Filed October 20, 2023 File No. 333-275111 Dear Tanya Zharov: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nicolas H.R. Dumont
Show Raw Text
United States securities and exchange commission logo
October 26, 2023
Tanya Zharov
General Counsel
Alvotech
1201 Wilson Blvd., Ste. 2130
Arlington, Virginia 22209
Re:Alvotech
Registration Statement on Form F-3
Filed October 20, 2023
File No. 333-275111
Dear Tanya Zharov:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nicolas H.R. Dumont